For: | Gionchetti P, Calabrese C, Tambasco R, Brugnera R, Straforini G, Liguori G, Fornarini GS, Riso D, Campieri M, Rizzello F. Role of conventional therapies in the era of biological treatment in Crohn’s disease. World J Gastroenterol 2011; 17(14): 1797-1806 [PMID: 21528051 DOI: 10.3748/wjg.v17.i14.1797] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v17/i14/1797.htm |
Number | Citing Articles |
1 |
Rosario Fornaro, Elisa Caratto, Michela Caratto, Francesco Fornaro, Giuseppe Caristo, Marco Frascio, Camilla Sticchi. Post-operative recurrence in Crohn's disease. Critical analysis of potential risk factors. An update. The Surgeon 2015; 13(6): 330 doi: 10.1016/j.surge.2015.04.002
|
2 |
Carla L. Brown, Karen Smith, Laura McCaughey, Daniel Walker. Colicin-like bacteriocins as novel therapeutic agents for the treatment of chronic biofilm-mediated infection. Biochemical Society Transactions 2012; 40(6): 1549 doi: 10.1042/BST20120241
|
3 |
Satoshi Yotsumoto, Yuito Muroi, Tatsuya Chiba, Rio Ohmura, Maki Yoneyama, Megumi Magarisawa, Kosuke Dodo, Naoki Terayama, Mikiko Sodeoka, Ryohei Aoyagi, Makoto Arita, Satoko Arakawa, Shigeomi Shimizu, Masato Tanaka. Hyperoxidation of ether-linked phospholipids accelerates neutrophil extracellular trap formation. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-15668-z
|
4 |
Miquel A. Gassull, Eduard Cabré. Crohn's Disease and Ulcerative Colitis. 2017; : 311 doi: 10.1007/978-3-319-33703-6_28
|
5 |
Xiaobing Wang, Feng Zhou, Junzhang Zhao, Rui Zhou, Meifang Huang, Jin Li, Wei Wang, Shufang Xu, Bing Xia. Elevated risk of opportunistic viral infection in patients with Crohn’s disease during biological therapies: a meta analysis of randomized controlled trials. European Journal of Clinical Pharmacology 2013; 69(11): 1891 doi: 10.1007/s00228-013-1559-8
|
6 |
Xiaobing Wang, Ge Wang, Jinghui Wang, Shi Liu, Rui Zhou, Liping Chen, Ting Wu, Meifang Huang, Jin Li, Lu Song, Bing Xia. Coagulation state in patients with Crohn’s disease. European Journal of Gastroenterology & Hepatology 2014; 26(9): 955 doi: 10.1097/MEG.0000000000000133
|
7 |
Kristen Corey, Peter Mattei, Neil Houston, Paul W Tebbey, Alan Menter, Peter CM van de Kerkhof, Alexa Boer Kimball. Psoriasis, a proof-of-principle condition for immune-mediated inflammatory disorders: perspectives toward optimal clinical trial design. Clinical Investigation 2012; 2(7): 671 doi: 10.4155/cli.12.57
|